Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Janusz T. Paweska is active.

Publication


Featured researches published by Janusz T. Paweska.


Veterinary Research | 2010

Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention

Michel Pépin; Michèle Bouloy; Brian H. Bird; Alan Kemp; Janusz T. Paweska

Rift Valley fever (RVF) virus is an arbovirus in the Bunyaviridae family that, from phylogenetic analysis, appears to have first emerged in the mid-19th century and was only identified at the begininning of the 1930s in the Rift Valley region of Kenya. Despite being an arbovirus with a relatively simple but temporally and geographically stable genome, this zoonotic virus has already demonstrated a real capacity for emerging in new territories, as exemplified by the outbreaks in Egypt (1977), Western Africa (1988) and the Arabian Peninsula (2000), or for re-emerging after long periods of silence as observed very recently in Kenya and South Africa. The presence of competent vectors in countries previously free of RVF, the high viral titres in viraemic animals and the global changes in climate, travel and trade all contribute to make this virus a threat that must not be neglected as the consequences of RVF are dramatic, both for human and animal health. In this review, we present the latest advances in RVF virus research. In spite of this renewed interest, aspects of the epidemiology of RVF virus are still not fully understood and safe, effective vaccines are still not freely available for protecting humans and livestock against the dramatic consequences of this virus.


PLOS Pathogens | 2009

Genetic Detection and Characterization of Lujo Virus, a New Hemorrhagic Fever–Associated Arenavirus from Southern Africa

Thomas Briese; Janusz T. Paweska; Laura K. McMullan; Stephen K. Hutchison; Craig Street; Gustavo Palacios; Marina L. Khristova; Jacqueline Weyer; Robert Swanepoel; Michael Egholm; Stuart T. Nichol; W. Ian Lipkin

Lujo virus (LUJV), a new member of the family Arenaviridae and the first hemorrhagic fever–associated arenavirus from the Old World discovered in three decades, was isolated in South Africa during an outbreak of human disease characterized by nosocomial transmission and an unprecedented high case fatality rate of 80% (4/5 cases). Unbiased pyrosequencing of RNA extracts from serum and tissues of outbreak victims enabled identification and detailed phylogenetic characterization within 72 hours of sample receipt. Full genome analyses of LUJV showed it to be unique and branching off the ancestral node of the Old World arenaviruses. The virus G1 glycoprotein sequence was highly diverse and almost equidistant from that of other Old World and New World arenaviruses, consistent with a potential distinctive receptor tropism. LUJV is a novel, genetically distinct, highly pathogenic arenavirus.


Archives of Virology | 2016

Taxonomy of the order Mononegavirales: update 2016

Claudio L. Afonso; Gaya K. Amarasinghe; Krisztián Bányai; Yīmíng Bào; Christopher F. Basler; Sina Bavari; Nicolás Bejerman; Kim R. Blasdell; François Xavier Briand; Thomas Briese; Alexander Bukreyev; Charles H. Calisher; Kartik Chandran; Jiāsēn Chéng; Anna N. Clawson; Peter L. Collins; Ralf G. Dietzgen; Olga Dolnik; Leslie L. Domier; Ralf Dürrwald; John M. Dye; Andrew J. Easton; Hideki Ebihara; Szilvia L. Farkas; Juliana Freitas-Astúa; Pierre Formenty; Ron A. M. Fouchier; Yànpíng Fù; Elodie Ghedin; Michael M. Goodin

In 2016, the order Mononegavirales was emended through the addition of two new families (Mymonaviridae and Sunviridae), the elevation of the paramyxoviral subfamily Pneumovirinae to family status (Pneumoviridae), the addition of five free-floating genera (Anphevirus, Arlivirus, Chengtivirus, Crustavirus, and Wastrivirus), and several other changes at the genus and species levels. This article presents the updated taxonomy of the order Mononegavirales as now accepted by the International Committee on Taxonomy of Viruses (ICTV).


Epidemiology and Infection | 2008

Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife

A. Evans; Francis Gakuya; Janusz T. Paweska; M. Rostal; L. Akoolo; P. J. Van Vuren; T. Manyibe; Joseph M. Macharia; T. G. Ksiazek; Daniel R. Feikin; Robert F. Breiman; M. Kariuki Njenga

Rift Valley fever virus (RVFV) is an arbovirus associated with periodic outbreaks, mostly on the African continent, of febrile disease accompanied by abortion in livestock, and a severe, fatal haemorrhagic syndrome in humans. However, the maintenance of the virus during the inter-epidemic period (IEP) when there is low or no disease activity detected in livestock or humans has not been determined. This study report prevalence of RVFV-neutralizing antibodies in sera (n=896) collected from 16 Kenyan wildlife species including at least 35% that were born during the 1999-2006 IEP. Specimens from seven species had detectable neutralizing antibodies against RVFV, including African buffalo, black rhino, lesser kudu, impala, African elephant, kongoni, and waterbuck. High RVFV antibody prevalence (>15%) was observed in black rhinos and ruminants (kudu, impala, buffalo, and waterbuck) with the highest titres (up to 1:1280) observed mostly in buffalo, including animals born during the IEP. All lions, giraffes, plains zebras, and warthogs tested were either negative or less than two animals in each species had low (<or= 1:16) titres of RVFV antibodies. Of 249 sera collected from five wildlife species during the 2006-2007 outbreak, 16 out of 19 (84%) of the ruminant (gerenuk, waterbuck, and eland) specimens had RVFV-neutralizing titres >or= 1:80. These data provide evidence that wild ruminants are infected by RVFV but further studies are required to determine whether these animals play a role in the virus maintenance between outbreaks and virus amplification prior to a noticeable outbreak.


Emerging Infectious Diseases | 2009

Nosocomial Outbreak of Novel Arenavirus Infection, Southern Africa

Janusz T. Paweska; Nivesh H. Sewlall; Thomas G. Ksiazek; Lucille Blumberg; Martin Hale; Ian W. Lipkin; Jacqueline Weyer; Stuart T. Nichol; Pierre E. Rollin; Laura K. McMullan; Christopher D. Paddock; Thomas Briese; Joy Mnyaluza; Thu-Ha Dinh; Victor Mukonka; Pamela Ching; Adriano Duse; Guy A. Richards; Gillian de Jong; Cheryl Cohen; Bridget Ikalafeng; Charles Mugero; Chika Asomugha; Mirriam M. Malotle; Dorothy M. Nteo; Eunice Misiani; Robert Swanepoel; Sherif R. Zaki

This case reinforces the need for strict screening of internationally transferred patients.


Journal of Virological Methods | 2003

IgG-sandwich and IgM-capture enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in domestic ruminants

Janusz T. Paweska; Felicity J. Burt; Fiona S. Anthony; Shirley Jacqueline Smith; Antoinette A. Grobbelaar; Janice E. Croft; Tomas G Ksiazek; Robert Swanepoel

The recent occurrence of the first confirmed outbreaks of Rift Valley fever in humans and livestock outside the African region, namely in the Kingdom of Saudi Arabia and Yemen, is of global medical and veterinary concern. Disadvantages of classical techniques for serological diagnosis of Rift Valley fever include health risk to laboratory personnel, restrictions for their use outside endemic areas and inability to distinguish between different classes of immunoglobulins. We report on the development and validation of sandwich and capture ELISAs (both based on inactivated antigen) for detection of IgG and IgM antibody to Rift Valley fever virus in bovine, caprine and ovine sera. Compared to virus neutralisation and haemagglutination-inhibition tests, the IgG sandwich ELISA was more sensitive in detection of the earliest immunological responses to infection or vaccination with Rift Valley fever virus. Its sensitivity and specificity derived from field data sets ranged in different ruminant species from 99.05 to 100% and from 99.1 to 99.9%, respectively. The specificity of IgM-capture ELISA varied between different species from 97.4 to 99.4%; its sensitivity was 100% in sheep tested 5-42 days post-infection. Our results in field-collected, experimental and post-vaccination sera demonstrate that these assays will be useful for epidemiological surveillance and control programmes, import/export veterinary certification, early diagnosis of infection, and for monitoring of immune response in vaccinated animals. As highly accurate and safe tests, they have the potential to replace traditional diagnostic methods, which pose biohazard risks limiting their use outside of endemic areas to high containment facilities.


Emerging Infectious Diseases | 2008

Genetic Determinants of Virulence in Pathogenic Lineage 2 West Nile Virus Strains

Elizabeth Magdelena Botha; Wanda Markotter; Marianne Wolfaardt; Janusz T. Paweska; Robert Swanepoel; Gustavo Palacios; Louis Hendrik Nel; Marietjie Venter

The most likely determinants are mutations in the nonstructural proteins encoding viral replication and protein cleavage mechanisms.


Emerging Infectious Diseases | 2007

Virus Detection and Monitoring of Viral Load in Crimean-Congo Hemorrhagic Fever Virus Patients

Roman Wölfel; Janusz T. Paweska; Nadine Petersen; Antoinette A. Grobbelaar; Patricia A. Leman; Roger Hewson; Marie-Claude Georges-Courbot; Anna Papa; Stephan Günther; Christian Drosten

We developed a real-time reverse transcription–-PCR that detected 1,164 copies/mL of Crimean-Congo hemorrhagic fever virus per milliliter of serum at 95% probability (probit analysis) and was 100% concordant with nested PCR on 63 samples from 31 patients with confirmed infection. Infected patients who died appeared to have higher viral loads; low viral loads correlated with IgG detection.


American Journal of Tropical Medicine and Hygiene | 2010

Risk Factors for Severe Rift Valley Fever Infection in Kenya, 2007

Amwayi S. Anyangu; L. Hannah Gould; Shahnaaz K. Sharif; Patrick M. Nguku; Jared Omolo; David Mutonga; Carol Y. Rao; Edith R. Lederman; David Schnabel; Janusz T. Paweska; Mark A. Katz; Allen W. Hightower; M. Kariuki Njenga; Daniel R. Feikin; Robert F. Breiman

A large Rift Valley fever (RVF) outbreak occurred in Kenya from December 2006 to March 2007. We conducted a study to define risk factors associated with infection and severe disease. A total of 861 individuals from 424 households were enrolled. Two hundred and two participants (23%) had serologic evidence of acute RVF infection. Of these, 52 (26%) had severe RVF disease characterized by hemorrhagic manifestations or death. Independent risk factors for acute RVF infection were consuming or handling products from sick animals (odds ratio [OR] = 2.53, 95% confidence interval [CI] = 1.78-3.61, population attributable risk percentage [PAR%] = 19%) and being a herds person (OR 1.77, 95% CI = 1.20-2.63, PAR% = 11%). Touching an aborted animal fetus was associated with severe RVF disease (OR = 3.83, 95% CI = 1.68-9.07, PAR% = 14%). Consuming or handling products from sick animals was associated with death (OR = 3.67, 95% CI = 1.07-12.64, PAR% = 47%). Exposures related to animal contact were associated with acute RVF infection, whereas exposures to mosquitoes were not independent risk factors.


Journal of Clinical Microbiology | 2009

Development and evaluation of a real-time reverse transcription-loop-mediated isothermal amplification assay for rapid detection of Rift Valley fever virus in clinical specimens.

C. A. Le Roux; Toru Kubo; Antoinette A. Grobbelaar; P. Jansen van Vuren; Jacqueline Weyer; L. H. Nel; Robert Swanepoel; Kouichi Morita; Janusz T. Paweska

This paper reports on the development and validation of a real-time reverse transcription-loop-mediated isothermal amplification assay (RT-LAMP) targeting the genomic large RNA segment of Rift Valley fever virus (RVFV). The set of six designed RT-LAMP primers identified strains of RVFV isolated in geographically distinct areas over a period of 50 years; there was no cross-reactivity with other genetically related and unrelated arboviruses. When testing serial sera and plasma from sheep experimentally infected with wild-type RVFV, there was 100% agreement between results of the RT-LAMP, a TaqMan-based real-time PCR, and virus isolation. Similarly, the assay had very high levels of diagnostic sensitivity and specificity when testing various clinical specimens from humans and animals naturally infected with the virus during recent outbreaks of the disease in Africa. The detection of specific viral genome targets in positive clinical specimens was achieved in less than 30 min. As a highly accurate, rapid, and very simple nucleic acid detection format, the RT-LAMP has the potential to be used in less-well-equipped laboratories in Africa and as a portable device during RVF outbreaks in remote areas, and it can be a valuable tool for the differential diagnosis of viral hemorrhagic fevers.

Collaboration


Dive into the Janusz T. Paweska's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jacqueline Weyer

National Health Laboratory Service

View shared research outputs
Top Co-Authors

Avatar

Petrus Jansen van Vuren

National Health Laboratory Service

View shared research outputs
Top Co-Authors

Avatar

Alan Kemp

National Health Laboratory Service

View shared research outputs
Top Co-Authors

Avatar

Patricia A. Leman

National Health Laboratory Service

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Antoinette A. Grobbelaar

National Health Laboratory Service

View shared research outputs
Top Co-Authors

Avatar

Felicity J. Burt

University of the Free State

View shared research outputs
Top Co-Authors

Avatar

Lucille Blumberg

National Health Laboratory Service

View shared research outputs
Top Co-Authors

Avatar

Nadia Storm

University of Pretoria

View shared research outputs
Researchain Logo
Decentralizing Knowledge